Clinical Trials
24 trialsNCT06502483 2026-04-21
PRISM
Dana-Farber Cancer Institute
Phase NA Completed
NCT01046487 2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1 Completed
NCT02476305 2026-01-20
CRYODESMO01
University Hospital, Strasbourg, France
Phase NA Completed
NCT01273168 2025-12-23
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT02228889 2025-06-06
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
Ohio State University
Phase NA Completed
NCT03190174 2025-02-17
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
Phase 1/2 Completed
NCT03785964 2025-01-31
DeFi
SpringWorks Therapeutics, Inc.
Phase 3 Completed
NCT02076906 2025-01-01
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
Children's National Research Institute
Phase 1 Completed
NCT03802084 2024-05-13
A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
Yonsei University
Phase 1/2 Completed
NCT01981551 2024-02-06
Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01265030 2023-06-26
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
MaineHealth
Phase 1/2 Completed
NCT02066181 2023-06-07
Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
National Cancer Institute (NCI)
Phase 3 Completed
NCT03459469 2023-03-01
Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059
Iterion Therapeutics
Phase 1 Completed
NCT03275818 2022-06-07
ABRADES
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Completed
NCT03966742 2022-03-25
Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis
Rabin Medical Center
Phase 2 Completed
NCT00068419 2020-02-19
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor
Children's Oncology Group
Phase 2 Completed
NCT01137916 2017-05-03
Study to Evaluate Imatinib in Desmoid Tumors
Heidelberg University
Phase 2 Completed
NCT00287846 2016-08-30
Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis
UNICANCER
Phase 1/2 Completed
NCT00474994 2016-01-20
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00003019 2014-07-25
Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
Children's Oncology Group
Phase 2 Completed
NCT00538850 2014-03-05
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Phase 3 Completed
NCT00030680 2013-08-27
Radiation Therapy in Treating Patients With Aggressive Fibromatoses
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT00002595 2013-07-10
Toremifene in Treating Patients With Desmoid Tumors
National Cancer Institute (NCI)
Phase 2 Completed
NCT00020579 2012-03-15
MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 1 Completed